R12 upgrade scoping and Oracle Audits
A global pharma was running an out of date version of Oracle’s ERP but was told that the cost of upgrade would be close to £500k. The cost would reflect a realignment of business process as well as the implementation of a costly analytics solution. The client had worked with Nymad in the past and called us in to validate the upgrade costs. At the same time the client was working through an audit with Oracle which was expected to pass with flying colours.
Nymad performed an in depth scoping study to identify all areas impacted by the upgrade including both out of the box and bespoke BI reporting. Nymad’s study proposed costs more than 50% less than our competitors and planned for an innovative approach to maintain the reporting capability without the need of the new solution. As a complimentary service, Nymad also worked with the client to dismiss an audit claim from Oracle for over £240k arising from the mistaken installation and use of the Enterprise Edition of the database.